S-1150 PLEUR-EVAC SAHARA PLUS CONTINUOUS REINFUSION AUTOTRANSFUSION SYSTEM— 510(k) K031554

Name: FDA 510(k) clearance K031554
Creator: U.S. Food and Drug Administration
Published: 2003-07-25

Substantially Equivalent

Genzyme Biosurgery

FDA 510(k) clearance K031554 for S-1150 PLEUR-EVAC SAHARA PLUS CONTINUOUS REINFUSION AUTOTRANSFUSION SYSTEM, Substantially Equivalent on 2003-07-25. Applicant: Genzyme Biosurgery. Device class: 2.

Clearance details

Applicant: Genzyme Biosurgery
Product code: Code CAC
Device class: Class 2
Regulation: 21 CFR 868.5830
Advisory panel: Anesthesiology
Date received: 2003-05-19
Decision date: 2003-07-25
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Fall River, MA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code CAC

view all

K241236 — XTRA Collection sets; XTRA Sequestration set X2024-08-16
K240426 — Aventus Clot Management System2024-05-14
K240584 — XTRA Autotransfusion System (with XTRA Bowl sets)2024-04-29
K231782 — FlowSaver Blood Return System (80-101)2023-07-14
K221483 — FlowSaver Blood Return System2023-02-17

More clearances from Genzyme Biosurgery

view all

K030212 — MONODEK SYNTHETIC ABSORBABLE SURGICAL SUTURE2003-03-27
K022989 — RADLITE TISSUE RETRACTOR SYSTEM2002-11-25
K022410 — SAPH-LOOP LIGATING LOOP2002-08-20

Adverse events under product code CAC

product code CAC

Death: 11
Malfunction: 477
Total: 488

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.